Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

By Grant R.   Shorvon S.D.  

Epilepsy Research, Vol. 42, Iss. 2, 2000-12 ,pp. : 89-95

Elsevier

Access to resources Recommend Favorite

Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day)

By Lanteri-Minet M.   Silhol F.   Piano V.   Donnet A.  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 173-176

Springer Publishing Company

Access to resources Recommend Favorite

High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients

By Wilson E.A.   Sills G.J.   Forrest G.   Brodie M.J.  

Epilepsy Research, Vol. 29, Iss. 2, 1998-01 ,pp. : 161-166

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''The KEEPER(TM) trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study'' [Epilepsy Res. 54 (2003) 153-162]

By Morrell M.J.   Leppik I.   French J.   Ferrendelli J.   Han J.   Magnus L.  

Epilepsy Research, Vol. 56, Iss. 2, 2003-10 ,pp. : 209-210

Elsevier

Access to resources Recommend Favorite

The effect of levetiracetam in startle disease

By Luef Gerhard   Löscher Wolfgang  

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 808-809

Springer Publishing Company

Access to resources Recommend Favorite